Fairness. Justice.
Rule of Law.
NEWSROOM
NJ Supreme Court Issues Opinion in Asbestos Duty-to-Warn Case
July 1, 2022On June 30, 2022, the New Jersey Supreme Court issued its decision in Fowler v. Akzo Nobel Chemicals, Inc., in which NJCJI jointly participated as amicus curiae with the United States Chamber of Commerce. The Court held that an asbestos manufacturer or supplier that places insufficient warnings on asbestos bags used in the workplace has breached More »
Read More »NJCJI President Testifies on Bill Seeking to Reduce Verbal Threshold for Auto Accident Lawsuits
June 24, 2022On June 20, 2022, NJCJI’s President, Anthony Anastasio, testified before the Senate Commerce Committee on Senate Bill 467 (S467). Part of a package of automobile insurance legislation advanced by Senate President Nicholas Scutari, S467 seeks to alter a New Jersey law that allows drivers to choose to limit their ability to bring accident lawsuits for More »
Read More »NJCJI Thanks Event Partner PPAG and Sponsors Genova Burns and Patterson Belknap for Their Support of the 2022 Spring Event
June 21, 2022NJCJI would like to thank its event partner, Princeton Public Affairs Group, and sponsors, Genova Burns and Patterson Belknap, for their support of the 2022 Spring Event. On Wednesday, June 15, 2022, NJCJI friends and supporters enjoyed a lovely meal at the storied Rat’s Restaurant at Grounds for Sculpture and engaged with our guest speaker, Senator Andrew Zwicker, about his vision More »
Read More »NJCJI Applauds the Committee on Rules of Practice and Procedure for its Unanimous Approval of Amendment to Rule 702
June 10, 2022On June 7, 2022, the Committee on Rules of Practice and Procedure voted unanimously to approve an amendment to Rule 702 of the Federal Rules of Evidence. This amendment clarifies that the proponent of expert testimony is required to demonstrate its admissibility by a preponderance of the evidence and that experts will not assert a More »
Read More »Institute for Legal Reform Releases Update on Third-Party Litigation Funding
April 15, 2022On April 7, 2022, the U.S. Chamber of Commerce’s Institute for Legal Reform (“ILR”) released an update on third-party litigation funding across the globe. Among the trends and developments ILR identified was the third-party litigation funding rule adopted by the District of New Jersey. NJCJI successfully advocated for this rule, Civ. Rule 7.1.1, last year. Read More »
Read More »ATRA Issues Report About the National Association of Attorneys General
April 8, 2022The American Tort Reform Association (“ATRA”) recently released a report about the National Association of Attorneys General (“NAAG”). Traditionally, NAAG’s function was to host a forum for state attorneys general to coordinate shared antitrust cases and manage multistate investigations and lawsuits. However, as ATRA’s report shows, NAAG’s mission has crept from promoting consistency across these More »
Read More »SCOTUS Hears Oral Argument in Arbitration Case
April 1, 2022On Monday, March 28, 2022, the Supreme Court of the United States heard oral argument in Southwest Airlines Co. v. Saxon. Southwest Airlines Co. v. Saxon asks the Supreme Court to determine whether workers who load/unload goods from vehicles that travel in interstate commerce but do not themselves physically transport the goods across state lines are More »
Read More »NJCJI Joins Coalition in Opposing FAIR Act
March 25, 2022NJCJI joined a coalition of business advocacy organizations in a letter opposing H.R. 963, the “Forced Arbitration Injustice Repeal (FAIR) Act.” The so-called FAIR Act would prohibit pre-dispute arbitration agreements that require arbitration in employment, consumer, antitrust, or civil rights disputes or that interfere with the ability of individual plaintiffs to participate in joint, class, More »
Read More »Merck Wins Dismissal in Fosamax Lawsuits
March 25, 2022On March 23, 2022, the Honorable Freda L. Wolfson, Chief Judge for the United States District Court for the District of New Jersey, issued a comprehensive opinion granting summary judgment to Merck in In re Fosamax (Alendronate Sodium) Products Liability Litigation. Chief Judge Wolfson’s decision ends about 500 lawsuits filed over the last fourteen years. In More »
Read More »